Callan Family Office LLC bought a new position in ChampionX Co. (NASDAQ:CHX - Free Report) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 14,612 shares of the company's stock, valued at approximately $397,000.
A number of other hedge funds and other institutional investors also recently made changes to their positions in the company. State Street Corp boosted its stake in shares of ChampionX by 1.7% during the 3rd quarter. State Street Corp now owns 7,422,097 shares of the company's stock worth $223,776,000 after acquiring an additional 122,622 shares in the last quarter. Geode Capital Management LLC grew its holdings in ChampionX by 1.4% during the third quarter. Geode Capital Management LLC now owns 4,617,387 shares of the company's stock valued at $139,239,000 after purchasing an additional 63,119 shares during the last quarter. Westchester Capital Management LLC raised its position in shares of ChampionX by 67.8% in the third quarter. Westchester Capital Management LLC now owns 2,828,139 shares of the company's stock valued at $85,268,000 after purchasing an additional 1,142,628 shares during the period. Charles Schwab Investment Management Inc. lifted its stake in shares of ChampionX by 2.1% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 2,679,414 shares of the company's stock worth $72,853,000 after buying an additional 56,283 shares during the last quarter. Finally, Van ECK Associates Corp boosted its holdings in shares of ChampionX by 0.3% during the 4th quarter. Van ECK Associates Corp now owns 2,639,352 shares of the company's stock worth $71,764,000 after buying an additional 9,056 shares during the period. 98.99% of the stock is owned by hedge funds and other institutional investors.
ChampionX Stock Performance
NASDAQ CHX traded down $0.14 during trading on Thursday, hitting $28.49. The company's stock had a trading volume of 3,357,938 shares, compared to its average volume of 3,131,685. ChampionX Co. has a 52 week low of $25.57 and a 52 week high of $39.95. The company has a quick ratio of 1.36, a current ratio of 1.99 and a debt-to-equity ratio of 0.32. The firm has a market cap of $5.44 billion, a P/E ratio of 17.27 and a beta of 2.28. The firm has a 50 day moving average price of $29.08 and a 200 day moving average price of $29.53.
ChampionX (NASDAQ:CHX - Get Free Report) last released its earnings results on Tuesday, February 4th. The company reported $0.50 EPS for the quarter, beating the consensus estimate of $0.47 by $0.03. ChampionX had a net margin of 8.81% and a return on equity of 19.84%. Equities research analysts forecast that ChampionX Co. will post 1.92 earnings per share for the current fiscal year.
ChampionX Announces Dividend
The company also recently declared a quarterly dividend, which will be paid on Friday, April 25th. Shareholders of record on Friday, April 4th will be issued a $0.095 dividend. The ex-dividend date is Friday, April 4th. This represents a $0.38 annualized dividend and a yield of 1.33%. ChampionX's dividend payout ratio (DPR) is 23.03%.
Wall Street Analysts Forecast Growth
Separately, Citigroup dropped their target price on shares of ChampionX from $45.00 to $40.00 and set a "buy" rating on the stock in a report on Thursday, November 14th.
Get Our Latest Stock Report on ChampionX
About ChampionX
(
Free Report)
ChampionX Corporation provides chemistry solutions, artificial lift systems, and engineered equipment and technologies to oil and gas companies worldwide. The company operates through four segments: Production Chemical Technologies, Production & Automation Technologies, Drilling Technologies, and Reservoir Chemical Technologies.
Featured Articles

Before you consider ChampionX, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ChampionX wasn't on the list.
While ChampionX currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of the 10 best stocks to own in 2025 and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.